Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Financial Result for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rekvina Laboratories Ltd has informed BSE that a meeting of its Board of Directors is scheduled for 21st May, 2026. The meeting will consider and approve the Audited Standalone Financial Results under Ind AS for the Quarter and Year ended 31st March, 2026. The company has also closed its trading window for designated persons from 1st April 2026 until 48 hours after the results are made public, as per its Insider Trading Code. This is a routine regulatory intimation filed pursuant to SEBI Listing Regulations and does not contain any financial figures or qualitative disclosures at this stage.
This is a standard procedural filing announcing an upcoming board meeting. No immediate impact on shareholders until actual financial results are disclosed. The trading window closure is normal practice ahead of earnings announcements.